Skip to main content
SpringerLink
Log in

Trovafloxacin vs Ceftriaxone/Cefpodoxime ± Erythromycin in Hospitalised Community-Acquired Pneumonia

  • Poster Presentations
  • Extended Abstract
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumoniae: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418–26

    PubMed  CAS  Google Scholar 

  2. Brighty KE, Gootz TD. The chemistry and biological profile of trovafloxacin. J Antimicrob Chemother 1997; 39 Suppl. B: 1–14

    Article  PubMed  CAS  Google Scholar 

  3. Teng R, Harris SC, Nix DE, et al. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J Antimicrob Chemother 1995; 36: 385–94

    Article  PubMed  CAS  Google Scholar 

  4. Vincent J, Venitz J, Teng R, et al. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. J Antimicrob Chemother 1997; 39 Suppl. B: 75–80

    Article  PubMed  CAS  Google Scholar 

  5. Andrews JM, Honeybourne D, Brenwald NP, et al. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 1997; 39: 797–802

    Article  PubMed  CAS  Google Scholar 

  6. Vincent J, Dogolo J, Baris B A, et al. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in man. Eur J Clin Microbiol Infect Dis 1998; 17: 427–30

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pfizer Central Research, Ramsgate Road, Sandwich, Kent, CT13 9NJ, England

    D. Williams Hopkins

  2. Pfizer Central Research, Sandwich, England

    R. Daniel

Authors
  1. D. Williams Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Daniel
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Trovafloxacin Study Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams Hopkins, D., Daniel, R. & the Trovafloxacin Study Group. Trovafloxacin vs Ceftriaxone/Cefpodoxime ± Erythromycin in Hospitalised Community-Acquired Pneumonia. Drugs 58 (Suppl 2), 318–319 (1999). https://doi.org/10.2165/00003495-199958002-00107

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958002-00107

Search

Navigation